Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / BLUE - Fulcrum Therapeutics Proposes Terms For IPO

BLUE - Fulcrum Therapeutics Proposes Terms For IPO

bluebird bio Inc.

Quick Take

Fulcrum Therapeutics (FULC) has filed to raise gross proceeds of $76.5 million from a U.S. IPO, according to an S-1/A registration statement.

The firm is developing treatments for genetically-defined diseases with high unmet medical need and an initial focus on rare diseases.

FULC is still in early Phase 1 safety trials for its lead candidate, so I view the IPO as more suited to long-term hold institutional investors.

Company & Technology

Cambridge, Massachusetts-based Fulcrum was founded in 2016 to develop treatments for genetically-defined diseases with high unmet medical need and

Read more ...
Stock Information
Company Name: bluebird bio Inc.
Stock Symbol: BLUE
Market: NASDAQ
Website: bluebirdbio.com
Menu
BLUE BLUE Quote BLUE Short BLUE News BLUE Articles BLUE Message Board
Get BLUE Alerts

News, Short Squeeze, Breakout and More Instantly...